SCHEMBL15958975

SCHEMBL15958975

O=C(O)c1cccc2c1CCN2Cc1ccc(F)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 2/20 0.51
PTGER4 P35408 2/20 0.48
PTGER2 P43116 1/20 0.48
LMNA P02545 5/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
NCOA3 Q9Y6Q9 1/20 0.46
HTT P42858 3/20 0.46
ALDH1A1 P00352 2/20 0.46
ALOX5 P09917 2/20 0.45
AKR1B1 P15121 1/20 0.44
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.44
KMT2A Q03164 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
EPHX2 P34913 1/20 0.43
HTR6 P50406 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
HDAC1 Q13547 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL957751 0.79 LMNA (0.48) PTGER4PTGER2LMNASMN1; SMN2L3MBTL1
SCHEMBL2610329 0.77 GPR52 (0.42) FABP4LMNASMN1; SMN2ALDH1A1MAPT
SCHEMBL14785546 0.75 PTGER1 (0.49) FABP4ALDH1A1MAPTMAPK1KMT2A
SCHEMBL14785493 0.74 ALDH1A1 (0.40) HTTALDH1A1MAPTKMT2A
SCHEMBL2998761 0.73 DHPS (0.62) LMNASMN1; SMN2L3MBTL1NCOA3HTT
SCHEMBL11345303 0.70 HTR6 (0.52) L3MBTL1AKR1B1KMT2ACYP2C19HTR6
SCHEMBL27982172 0.69 ALDH1A1 (0.43) L3MBTL1ALDH1A1TDP1
SCHEMBL8042876 0.69 ALDH1A1 (0.44) LMNASMN1; SMN2L3MBTL1NCOA3HTT
SCHEMBL6695776 0.68 FABP4 (1.00) FABP4
SCHEMBL28801601 0.67 ALDH1A1 (0.61) LMNASMN1; SMN2L3MBTL1NCOA3HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421825-B9 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2014-08-20 EP disclosed